Showing results (61-70 of 410) with videos related to
Sort By:
Pageof 41
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1985
[Therapeutic results in acute myelogenous leukemia in the years from 1970 to 1982]E Kurrle, D Hoelzer, H HeimpelAnnals of Hematology|December 19, 1998
L-tryptophan-related eosinophilia-myalgia syndrome possibly associated with a chronic B-lymphocytic leukemiaA Böhme, M Wolter, D HoelzerBlut|November 1, 1976
Re-entry of resting leukaemic blood cells into proliferation in human acute leukaemia during diffusion chamber cultureD Hoelzer, H Schmücker, E KurrleAnnals of Hematology|February 1, 1992
Presence of more than two rearranged immunoglobulin heavy-chain genes in adult precursor B-cell acute lymphoblastic leukemiaC Schardt, D Hoelzer, A GanserAmerican Journal of Clinical Oncology|January 1, 1991
The role of GM-CSF, G-CSF, interleukin-3, and erythropoietin in myelodysplastic syndromesA Ganser, G Seipelt, D HoelzerKlinische Padiatrie|May 1, 1984
[Acute myelogenous leukemia in children under 2 years of age: studies and treatment results in 23 children in the AML therapy study BFM-78]U Creutzig, A Schaaff, J Ritter, et al.British Journal of Haematology|October 29, 2000
Primary myelosarcomas are associated with a high rate of relapse: report on 34 children from the acute myeloid leukaemia-Berlin-Frankfurt-Münster studiesD Reinhardt, A Pekrun, M Lakomek, et al.Klinische Padiatrie|August 8, 2002
[Liposomal daunorubicine combined with cytarabine in the treatment of relapsed/refractory acute myeloid leukemia in children]D Reinhardt, G Hempel, G Fleischhack, et al.Leukemia|October 31, 2003
Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93T Lehrnbecher, D Varwig, J Kaiser, et al.Studies in Health Technology and Informatics|June 29, 1999
Computer-aided documentation and therapy planning in pediatric oncologyT Wiedemann, P Knaup, A Bachert, et al.Pageof 41